Other Events ·
NovaBridge Biosciences dismissed its independent registered public accounting firm, PricewaterhouseCoopers LLP…
NBPNovaBridge Biosciences
NovaBridge Biosciences dismissed its independent registered public accounting firm, PricewaterhouseCoopers LLP, effective June 16, 2026, and appointed Deloitte Touche Tohmatsu Certified Public Accountants LLP as its new auditor for the fiscal year ending December 31, 2026. The company reported no disagreements with PwC regarding accounting principles or auditing scope, though it noted material weaknesses in information technology general controls for the fiscal years 2024 and 2025. NovaBridge Biosciences is a biotechnology company focused on drug discovery and development.